2.5/1000 4222 (Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg)
Generic Name: metformin/saxagliptin
Pill imprint 2.5/1000 4222 has been identified as Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg.
Kombiglyze XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- metformin/saxagliptin
- Imprint:
- 2.5/1000 4222
- Strength:
- metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00003-4222
- Inactive Ingredients:
- carboxymethylcellulose sodium
hypromellose 2208 (15000 mPa.s)
magnesium stearate
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00310-6125 | AstraZeneca Pharmaceuticals LP |
Note: Inactive ingredients may vary.
More about Kombiglyze XR (metformin / saxagliptin)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
